← Back to Patent Explorer
EP0138111B1 Expired / Lapsed EP ⏱️ 0.0 years remaining

Superoxide dismutase cloning and expression in microorganisms

Assignee: Novartis Vaccines and Diagnostics Inc
•
Filing: 1984-09-25
•
Granted: 1991-11-21
•
Expires: 2004-09-25
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention provides a DNA construct comprising a functional vector for expression in E. coli comprising in downstream order of transcription: (1) a promoter, (2) a ribosomal binding site, (3) an initiation codon, (4) a human cytoplasmic Cu/Zn superoxide dismutase structural gene, or alleles thereof, in reading frame with said initiation codon having a stop codon at the 3'-terminus of said gene and (5) a transcription terminator, wherein said DNA construct, upon expression in E. coli, expresses non-acetylated active human cytoplasmic Cu/Zn superoxide dismutase. The invention also provides a method for preparing a polypeptide comprising non-acetylated enzymatically active human cytoplasmic Cu/Zn superoxide dismutase that differs by no more than four amino acids from naturally-occurring human cytoplasmic Cu/Zn superoxide dismutase, said method comprising growing E. coli containing a DNA construct of the invention in a nutrient medium and isolating the resulting non-acetylated enzymatically active human cytoplasmic superoxide dismutase.

Inventors

  • 👤 Robert A. Hallewell
  • 👤 Guy T. Mullenbach

Bibliographic Details

Application Number —
Jurisdiction EP
Data Source google_patents
Last Synchronized 2026-10-28 18:01
CPC Classifications
C; C12; C12N; C12N9/00; C12N9/0004; C12N9/0089; C12N15/00; C12N15/09; C12N15/11; C12N15/62; C12N15/63; C12N15/70; C12N15/79; C12N15/80; C12N15/81; C07; C07K; C07K2319/00; C07K2319/01; C07K2319/02; C07K2319/70; C07K2319/735; C07K2319/90

Claims Analysis

Total Claims: 2
Claim 1
Independent Claim 68 words
A method for producing an acetylated human superoxide dismutase, said method comprising introducing into yeast a DNA sequence encoding said human superoxide dismutase and having an acetylation signal sequence at its 5'-end encoding for glycine or alanine at the first position followed by a polar amino acid at the second position, which acetylation signal sequence causes the yeast host to acetylate the N-terminal amino acid on the polypeptide.
Claim 2
Dependent Claim 22 words
A method as in claim 1, wherein the polar amino acid is selected from the group consisting of aspartate, serine and threonine.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Maintenance schedule is calculated for granted US utility patents.

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag